Izzet Ozgurluk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Izzet Ozgurluk has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Berna Turhan
Radiology Department, Ankara Etlik City Hospital, Ankara 06170, Turkey
4 shared publications - Hüseyin Levent Keskin
Department of Obstetrics and Gynecology, Ufuk University Faculty of Medicine, Ankara, Türkiye
4 shared publications - Zeynep Seyhanli
Department of Obstetrics and Gynecology, Division of Perinatology Ankara Etlik City Hospital Ankara Turkey
4 shared publications - Ahmet Kurt
Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Turkey
3 shared publications - Dilek Sahin
Perinatology Department Ankara Bilkent City Hospital Ankara Turkey
3 shared publications - Gülin Feykan Yeğin
Obstetrics and Gynecology Department, Ankara Etlik City Hospital, Ankara 06170, Turkey
3 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8808
Pelvic Floor Morphometric Differences in Women with Urinary Incontinence: A Comparative Urogynecologic Study Using Static MRI
Background/Objectives: To compare static pelvic floor MRI morphometry between women with symptom-defined urinary incontinence (UI) and continent women and to examine whether observed differences persisted after accounting for parity and other clinical covariates. Methods: This retrospective cross-sectional comparative study included 131 women: 81 classified as having symptom-defined UI and 50 continent participants. UI classification was based on self-reported involuntary urinary leakage together with at least one positive response in the urinary distress domain of the PFDI-20; no urodynamic or objective continence test was used for study classification. Static 3.0-T pelvic MRI at rest was used to measure puborectalis thickness, genital hiatus dimensions, urethral morphology, obturator internus thickness, and rectus muscle thickness. Group comparisons, exploratory within-sample ROC analyses, and parsimonious logistic regression models were performed. Results: Women with symptom-defined UI had lower bilateral puborectalis thickness (left: 5.54 ± 1.59 vs. 6.76 ± 1.33 mm; right: 5.53 ± 1.67 vs. 6.51 ± 1.46 mm; p ≤ 0.001) and larger genital hiatus width (105.54 ± 15.97 vs. 93.07 ± 15.07 mm; p < 0.001) and area (median 396.9 vs. 308.1 mm2; p < 0.001). Urethral diameter was also greater (12.34 ± 1.91 vs. 11.60 ± 1.45 mm; p = 0.021). Discrimination was moderate for genital hiatus width (AUC = 0.720) and left puborectalis thickness (AUC = 0.730). In separate parity-adjusted models, hiatus dimensions and bilateral puborectalis thickness remained associated with UI. None retained statistical significance when age, BMI, parity, and multiple correlated morphometric measures were entered together in broader models. Conclusions: Women with symptom-defined UI showed differences in puborectalis thickness and genital hiatus dimensions on static MRI. These associations were evident in unadjusted and parity-adjusted analyses but were attenuated in broader multivariable models, indicating important confounding and shared variance with clinical factors. The exploratory thresholds were derived within this sample and should not be interpreted as diagnostic cut-offs. Static MRI morphometry may help characterize pelvic floor anatomy, but the present data do not support its use as a stand-alone diagnostic test for UI.
- 11 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8808
Open AccessPelvic Floor Morphometric Differences in Women with Urinary Incontinence: A Comparative Urogynecologic Study Using Static MRI
Background/Objectives: To compare static pelvic floor MRI morphometry between women with symptom-defined urinary incontinence (UI) and continent women and to examine whether observed differences persisted after accounting for parity and other clinical covariates. Methods: This retrospective cross-sectional comparative study included 131 women: 81 classified as having symptom-defined UI and 50 continent participants. UI classification was based on self-reported involuntary urinary leakage together with at least one positive response in the urinary distress domain of the PFDI-20; no urodynamic or objective continence test was used for study classification. Static 3.0-T pelvic MRI at rest was used to measure puborectalis thickness, genital hiatus dimensions, urethral morphology, obturator internus thickness, and rectus muscle thickness. Group comparisons, exploratory within-sample ROC analyses, and parsimonious logistic regression models were performed. Results: Women with symptom-defined UI had lower bilateral puborectalis thickness (left: 5.54 ± 1.59 vs. 6.76 ± 1.33 mm; right: 5.53 ± 1.67 vs. 6.51 ± 1.46 mm; p ≤ 0.001) and larger genital hiatus width (105.54 ± 15.97 vs. 93.07 ± 15.07 mm; p < 0.001) and area (median 396.9 vs. 308.1 mm2; p < 0.001). Urethral diameter was also greater (12.34 ± 1.91 vs. 11.60 ± 1.45 mm; p = 0.021). Discrimination was moderate for genital hiatus width (AUC = 0.720) and left puborectalis thickness (AUC = 0.730). In separate parity-adjusted models, hiatus dimensions and bilateral puborectalis thickness remained associated with UI. None retained statistical significance when age, BMI, parity, and multiple correlated morphometric measures were entered together in broader models. Conclusions: Women with symptom-defined UI showed differences in puborectalis thickness and genital hiatus dimensions on static MRI. These associations were evident in unadjusted and parity-adjusted analyses but were attenuated in broader multivariable models, indicating important confounding and shared variance with clinical factors. The exploratory thresholds were derived within this sample and should not be interpreted as diagnostic cut-offs. Static MRI morphometry may help characterize pelvic floor anatomy, but the present data do not support its use as a stand-alone diagnostic test for UI.
- Open Access
- 21 September 2026
- Published by MDPI AG in Preprints.org
Pelvic Floor Morphometric Differences in Women with Urinary Incontinence: A Comparative Urogynecologic Study Using Static MRI
Background/Objectives: To compare static pelvic floor MRI morphometry between women with symptom-defined urinary incontinence (UI) and continent women and to examine whether observed differences persisted after accounting for parity and other clinical covariates. Methods: This retrospective cross-sectional comparative study included 131 women: 81 classified as having symptom-defined UI and 50 continent participants. UI classification was based on self-reported involuntary urinary leakage together with at least one positive response in the urinary distress domain of the PFDI-20; no urodynamic or objective continence test was used for study classification. Static 3.0-T pelvic MRI at rest was used to measure puborectalis thickness, genital hiatus dimensions, urethral morphology, obturator internus thickness, and rectus muscle thickness. Group comparisons, exploratory within-sample ROC analyses, and parsimonious logistic regression models were performed. Results: Women with symptom-defined UI had lower bilateral puborectalis thickness (left: 5.54 ± 1.59 vs. 6.76 ± 1.33 mm; right: 5.53 ± 1.67 vs. 6.51 ± 1.46 mm; p ≤ 0.001) and larger genital hiatus width (105.54 ± 15.97 vs. 93.07 ± 15.07 mm; p < 0.001) and area (median 396.9 vs. 308.1 mm²; p < 0.001). Urethral diameter was also greater (12.34 ± 1.91 vs. 11.60 ± 1.45 mm; p = 0.021). Discrimination was moderate for genital hiatus width (AUC = 0.720) and left puborectalis thickness (AUC = 0.730). In separate parity-adjusted models, hiatus dimensions and bilateral puborectalis thickness remained associated with UI. None retained statistical significance when age, BMI, parity, and multiple correlated morphometric measures were entered together in broader models. Conclusions: Women with symptom-defined UI showed differences in puborectalis thickness and genital hiatus dimensions on static MRI. These associations were evident in unadjusted and parity-adjusted analyses but were attenuated in broader multivariable models, indicating important confounding and shared variance with clinical factors. The exploratory thresholds were derived within this sample and should not be interpreted as diagnostic cut-offs. Static MRI morphometry may help characterize pelvic floor anatomy, but the present data do not support its use as a stand-alone diagnostic test for UI.
- 21 September 2026
- Published by MDPI AG in Preprints.org
Open AccessPelvic Floor Morphometric Differences in Women with Urinary Incontinence: A Comparative Urogynecologic Study Using Static MRI
Background/Objectives: To compare static pelvic floor MRI morphometry between women with symptom-defined urinary incontinence (UI) and continent women and to examine whether observed differences persisted after accounting for parity and other clinical covariates. Methods: This retrospective cross-sectional comparative study included 131 women: 81 classified as having symptom-defined UI and 50 continent participants. UI classification was based on self-reported involuntary urinary leakage together with at least one positive response in the urinary distress domain of the PFDI-20; no urodynamic or objective continence test was used for study classification. Static 3.0-T pelvic MRI at rest was used to measure puborectalis thickness, genital hiatus dimensions, urethral morphology, obturator internus thickness, and rectus muscle thickness. Group comparisons, exploratory within-sample ROC analyses, and parsimonious logistic regression models were performed. Results: Women with symptom-defined UI had lower bilateral puborectalis thickness (left: 5.54 ± 1.59 vs. 6.76 ± 1.33 mm; right: 5.53 ± 1.67 vs. 6.51 ± 1.46 mm; p ≤ 0.001) and larger genital hiatus width (105.54 ± 15.97 vs. 93.07 ± 15.07 mm; p < 0.001) and area (median 396.9 vs. 308.1 mm²; p < 0.001). Urethral diameter was also greater (12.34 ± 1.91 vs. 11.60 ± 1.45 mm; p = 0.021). Discrimination was moderate for genital hiatus width (AUC = 0.720) and left puborectalis thickness (AUC = 0.730). In separate parity-adjusted models, hiatus dimensions and bilateral puborectalis thickness remained associated with UI. None retained statistical significance when age, BMI, parity, and multiple correlated morphometric measures were entered together in broader models. Conclusions: Women with symptom-defined UI showed differences in puborectalis thickness and genital hiatus dimensions on static MRI. These associations were evident in unadjusted and parity-adjusted analyses but were attenuated in broader multivariable models, indicating important confounding and shared variance with clinical factors. The exploratory thresholds were derived within this sample and should not be interpreted as diagnostic cut-offs. Static MRI morphometry may help characterize pelvic floor anatomy, but the present data do not support its use as a stand-alone diagnostic test for UI.
- Open Access
- 4 September 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
Determination of the genital hygiene behaviors of pregnant women with diabetes mellitus: a cross-sectional study
Background: It is important to understand the genital hygiene behaviors of pregnant women with diabetes mellitus to prevent urogenital tract infections and to ensure healthy pregnancy and childbirth. The aim of this study was to determine genital hygiene behaviors and identify factors associated with GHBI scores among pregnant women with diabetes mellitus. Methods: This descriptive and cross-sectional study was conducted with pregnant women with diabetes mellitus between June 2023 and June 2024 [ n = 139]. The data were collected via the “Genital Hygiene Behaviors Inventory [GHBI]”. Comparisons of GHBI scores across participant characteristics were analyzed using independent-samples t-tests and one-way analysis of variance. Factors independently associated with GHBI scores were examined using multivariable linear regression analysis. Ethics committee approval was obtained. Results: The mean score of the GHBI was 80.50 ± 9.62. Only 5% of pregnant women with diabetes mellitus reported receiving genital hygiene education during pregnancy. In univariate analyses, GHBI scores differed significantly according to age, income status, physician-diagnosed health problems, panty liner use, cleaning direction, use of toilet paper after toileting, underwear characteristics, frequency of underwear change, laundering underwear in hot water, actions taken when experiencing genital problems, and receipt of genital hygiene education (all p <.05). In multivariable linear regression analysis, age, income status, and pre-pregnancy diabetes remained independently associated with GHBI scores (all p <.05). Conclusions: Genital hygiene behaviors of pregnant women with diabetes mellitus were associated with several sociodemographic characteristics and hygiene-related practices. Integrating genital hygiene education and counseling into routine antenatal care may help support healthy hygiene behaviors in this population. The findings should be interpreted in light of the single-centre, cross-sectional design of the study.
- 4 September 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
Open AccessDetermination of the genital hygiene behaviors of pregnant women with diabetes mellitus: a cross-sectional study
Background: It is important to understand the genital hygiene behaviors of pregnant women with diabetes mellitus to prevent urogenital tract infections and to ensure healthy pregnancy and childbirth. The aim of this study was to determine genital hygiene behaviors and identify factors associated with GHBI scores among pregnant women with diabetes mellitus. Methods: This descriptive and cross-sectional study was conducted with pregnant women with diabetes mellitus between June 2023 and June 2024 [ n = 139]. The data were collected via the “Genital Hygiene Behaviors Inventory [GHBI]”. Comparisons of GHBI scores across participant characteristics were analyzed using independent-samples t-tests and one-way analysis of variance. Factors independently associated with GHBI scores were examined using multivariable linear regression analysis. Ethics committee approval was obtained. Results: The mean score of the GHBI was 80.50 ± 9.62. Only 5% of pregnant women with diabetes mellitus reported receiving genital hygiene education during pregnancy. In univariate analyses, GHBI scores differed significantly according to age, income status, physician-diagnosed health problems, panty liner use, cleaning direction, use of toilet paper after toileting, underwear characteristics, frequency of underwear change, laundering underwear in hot water, actions taken when experiencing genital problems, and receipt of genital hygiene education (all p <.05). In multivariable linear regression analysis, age, income status, and pre-pregnancy diabetes remained independently associated with GHBI scores (all p <.05). Conclusions: Genital hygiene behaviors of pregnant women with diabetes mellitus were associated with several sociodemographic characteristics and hygiene-related practices. Integrating genital hygiene education and counseling into routine antenatal care may help support healthy hygiene behaviors in this population. The findings should be interpreted in light of the single-centre, cross-sectional design of the study.
- Open Access
- 10 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1375
Evaluation of the Relationship Between Adenomyosis and Cervical Elastography Parameters
Objectives: We aim to investigate cervical biomechanical alterations associated with adenomyosis using shear-wave elastography (SWE), and to explore the discriminative potential of cervical SWE parameters. Methods: In this prospective study, 84 patients with adenomyosis, diagnosed both clinically and by ultrasonography according to the MUSA parameters, and 65 healthy women underwent elastography to the cervix with SWE. Six areas of the cervix were evaluated: anterior and posterior internal os, middle part of the cervix, and external os. Results: The adenomyosis group showed a significantly higher cervical length (27.3 ± 5.5 mm vs. 23.8 ± 4.6 mm), as well as greater anterior (11.3 ± 2.4 mm vs. 9.9 ± 1.3 mm) and posterior (11.3 ± 2.2 mm vs. 10.5 ± 1.8 mm) cervical measurements compared with the controls (p < 0.001). SWE showed higher stiffness measurements for the anterior and posterior internal os (22.3 ± 5.4 kPa and 22.2 ± 4.9 kPa) compared with the controls (15.5 ± 5.8 kPa and 15.7 ± 5.6 kPa, respectively; p < 0.001). Receiver operating characteristic analysis demonstrated high discrimination for these measurements, with area under curve values of 0.804 for the anterior internal os and 0.808 of posterior internal os. Optimal cut-offs were 17.5 kPa (sensitivity 82%, specificity 70%) and 18.5 kPa (sensitivity 81%, specificity 74%). Conclusions: Cervical elastography may serve as a non-invasive adjunctive tool for exploring disease-related biomechanical changes and for supporting imaging-based assessment of adenomyosis.
- 10 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1375
Open AccessEvaluation of the Relationship Between Adenomyosis and Cervical Elastography Parameters
Objectives: We aim to investigate cervical biomechanical alterations associated with adenomyosis using shear-wave elastography (SWE), and to explore the discriminative potential of cervical SWE parameters. Methods: In this prospective study, 84 patients with adenomyosis, diagnosed both clinically and by ultrasonography according to the MUSA parameters, and 65 healthy women underwent elastography to the cervix with SWE. Six areas of the cervix were evaluated: anterior and posterior internal os, middle part of the cervix, and external os. Results: The adenomyosis group showed a significantly higher cervical length (27.3 ± 5.5 mm vs. 23.8 ± 4.6 mm), as well as greater anterior (11.3 ± 2.4 mm vs. 9.9 ± 1.3 mm) and posterior (11.3 ± 2.2 mm vs. 10.5 ± 1.8 mm) cervical measurements compared with the controls (p < 0.001). SWE showed higher stiffness measurements for the anterior and posterior internal os (22.3 ± 5.4 kPa and 22.2 ± 4.9 kPa) compared with the controls (15.5 ± 5.8 kPa and 15.7 ± 5.6 kPa, respectively; p < 0.001). Receiver operating characteristic analysis demonstrated high discrimination for these measurements, with area under curve values of 0.804 for the anterior internal os and 0.808 of posterior internal os. Optimal cut-offs were 17.5 kPa (sensitivity 82%, specificity 70%) and 18.5 kPa (sensitivity 81%, specificity 74%). Conclusions: Cervical elastography may serve as a non-invasive adjunctive tool for exploring disease-related biomechanical changes and for supporting imaging-based assessment of adenomyosis.
- Open Access
- 23 January 2026
- Published by Spandidos Publications in Oncology Letters
- Vol. 31 (3) , 1-10
Unveiling mitochondrial DNA copy number alterations: Insights into progression from cervical intraepithelial neoplasia to cervical cancer
Mitochondrial dysfunction has been increasingly implicated in carcinogenesis, with alterations in mitochondrial DNA (mtDNA) copy number reported across various cancer types. However, the role of mtDNA copy number changes in the progression from cervical intraepithelial neoplasia to invasive cervical cancer remains insufficiently characterized. The present study aimed to elucidate the association between mitochondrial DNA copy number (mtCN) variations and the progression of cervical intraepithelial neoplasia (CIN) to cervical cancer, and to evaluate the potential of mtCN as a biomarker for cervical cancer risk stratification. A cohort of 100 participants from the Gynecology and Obstetrics Clinic of Ankara Etlik City Hospital (Ankara, Türkiye) was enrolled. Cervical samples from the participants were categorized into four groups as follows: Normal (n=32), low‑grade squamous intraepithelial lesion (CIN1; n=21), high‑grade squamous intraepithelial lesion (CIN2/3; n=23) and cervical cancer (n=8). The remaining 16 samples were excluded from the analysis due to inadequate DNA yield or quality. Quantitative PCR was employed to quantify mtCN relative to nuclear DNA. Differences in mtCN according to disease category, smoking status and human papillomavirus (HPV) status were analyzed, and logistic regression modeling was performed to identify independent predictors of high‑risk cervical disease (HSIL and invasive cancer). The study revealed a statistically significant stepwise increase in mtCN concomitant with increasing disease severity, reaching the highest level in cervical cancer. Notably, HPV‑positive samples exhibited elevated mtCN levels compared with HPV‑negative samples. In addition, smoking was associated with a significant increase in mtCN within cervical tissues. A triple model comprising mtCN fold change, smoking status and HPV status demonstrated superior predictive performance for distinguishing high‑risk cervical disease, with a sensitivity of 79% and specificity of 92%. The findings indicate that mtCN alterations are associated with the progression of CIN to cervical cancer, particularly in cases who are HPV positive and smoke. To substantiate these findings and evaluate their clinical utility, larger longitudinal studies with standardized assessment protocols are imperative. However, the present study underscores the potential of mtCN as a biomarker for cervical cancer risk assessment and highlights the necessity for continued exploration into its role in tumorigenesis and diagnostic applications.
- 23 January 2026
- Published by Spandidos Publications in Oncology Letters
- Vol. 31 (3) , 1-10
Open AccessUnveiling mitochondrial DNA copy number alterations: Insights into progression from cervical intraepithelial neoplasia to cervical cancer
Mitochondrial dysfunction has been increasingly implicated in carcinogenesis, with alterations in mitochondrial DNA (mtDNA) copy number reported across various cancer types. However, the role of mtDNA copy number changes in the progression from cervical intraepithelial neoplasia to invasive cervical cancer remains insufficiently characterized. The present study aimed to elucidate the association between mitochondrial DNA copy number (mtCN) variations and the progression of cervical intraepithelial neoplasia (CIN) to cervical cancer, and to evaluate the potential of mtCN as a biomarker for cervical cancer risk stratification. A cohort of 100 participants from the Gynecology and Obstetrics Clinic of Ankara Etlik City Hospital (Ankara, Türkiye) was enrolled. Cervical samples from the participants were categorized into four groups as follows: Normal (n=32), low‑grade squamous intraepithelial lesion (CIN1; n=21), high‑grade squamous intraepithelial lesion (CIN2/3; n=23) and cervical cancer (n=8). The remaining 16 samples were excluded from the analysis due to inadequate DNA yield or quality. Quantitative PCR was employed to quantify mtCN relative to nuclear DNA. Differences in mtCN according to disease category, smoking status and human papillomavirus (HPV) status were analyzed, and logistic regression modeling was performed to identify independent predictors of high‑risk cervical disease (HSIL and invasive cancer). The study revealed a statistically significant stepwise increase in mtCN concomitant with increasing disease severity, reaching the highest level in cervical cancer. Notably, HPV‑positive samples exhibited elevated mtCN levels compared with HPV‑negative samples. In addition, smoking was associated with a significant increase in mtCN within cervical tissues. A triple model comprising mtCN fold change, smoking status and HPV status demonstrated superior predictive performance for distinguishing high‑risk cervical disease, with a sensitivity of 79% and specificity of 92%. The findings indicate that mtCN alterations are associated with the progression of CIN to cervical cancer, particularly in cases who are HPV positive and smoke. To substantiate these findings and evaluate their clinical utility, larger longitudinal studies with standardized assessment protocols are imperative. However, the present study underscores the potential of mtCN as a biomarker for cervical cancer risk assessment and highlights the necessity for continued exploration into its role in tumorigenesis and diagnostic applications.
- 2 August 2025
- Published by Wiley in Journal of Ultrasound in Medicine
Diaphragmatic Function in Late‐Onset FGR Insights from Ultrasound‐Based Quantification
Objectives: We aimed to investigate diaphragm functions via ultrasonography in fetuses with late‐onset fetal growth restriction (LO‐FGR) and to examine the relationship of these parameters with composite adverse perinatal outcomes (CAPO).Methods: This prospective cohort study included 40 fetuses with LO‐FGR and 40 healthy controls matched for gestational age. Diaphragmatic functions were evaluated using ultrasonography by measuring diaphragm thickness (DT) during inspiration and expiration, diaphragm thickness fraction (DTF), diaphragm excursion (DE), and costophrenic angle (CPA). CAPO was defined as a 5‐minute Apgar score of less than 7 and/or infant respiratory complications or admission to the neonatal intensive care unit (NICU). The LO‐FGR group was categorized into 2 subgroups: those with CAPO and those without. Statistical analyses evaluated the association between sonographic measurements of the diaphragm and CAPO.Results: In the LO‐FGR group, DT (both inspiratory and expiratory), DTF, DE, and expiratory CPA were markedly reduced (P < .001). In LO‐FGR cases that developed CAPO, DT (both inspiratory and expiratory), DTF, and DE were significantly lower (P < .001). Inspiratory DT exhibited the best predictive value for CAPO (area under the curve [AUC]: 0.923), followed by expiratory DT (AUC: 0.865) and DE (AUC: 0.786). Additionally, DUS parameters exhibited better predictive capability relative to Doppler measurements.Conclusion: Diaphragmatic ultrasonography‐derived functional parameters serve as clinically relevant biomarkers for predicting unfavorable perinatal outcomes in LO‐FGR. The incorporation of DUS into standard prenatal assessment procedures may enhance the monitoring and management of LO‐FGR cases.
- 2 August 2025
- Published by Wiley in Journal of Ultrasound in Medicine
Diaphragmatic Function in Late‐Onset FGR Insights from Ultrasound‐Based Quantification
Objectives: We aimed to investigate diaphragm functions via ultrasonography in fetuses with late‐onset fetal growth restriction (LO‐FGR) and to examine the relationship of these parameters with composite adverse perinatal outcomes (CAPO).Methods: This prospective cohort study included 40 fetuses with LO‐FGR and 40 healthy controls matched for gestational age. Diaphragmatic functions were evaluated using ultrasonography by measuring diaphragm thickness (DT) during inspiration and expiration, diaphragm thickness fraction (DTF), diaphragm excursion (DE), and costophrenic angle (CPA). CAPO was defined as a 5‐minute Apgar score of less than 7 and/or infant respiratory complications or admission to the neonatal intensive care unit (NICU). The LO‐FGR group was categorized into 2 subgroups: those with CAPO and those without. Statistical analyses evaluated the association between sonographic measurements of the diaphragm and CAPO.Results: In the LO‐FGR group, DT (both inspiratory and expiratory), DTF, DE, and expiratory CPA were markedly reduced (P < .001). In LO‐FGR cases that developed CAPO, DT (both inspiratory and expiratory), DTF, and DE were significantly lower (P < .001). Inspiratory DT exhibited the best predictive value for CAPO (area under the curve [AUC]: 0.923), followed by expiratory DT (AUC: 0.865) and DE (AUC: 0.786). Additionally, DUS parameters exhibited better predictive capability relative to Doppler measurements.Conclusion: Diaphragmatic ultrasonography‐derived functional parameters serve as clinically relevant biomarkers for predicting unfavorable perinatal outcomes in LO‐FGR. The incorporation of DUS into standard prenatal assessment procedures may enhance the monitoring and management of LO‐FGR cases.
- Open Access
- 14 June 2025
- Published by Wiley in Hong Kong Journal of Emergency Medicine
- Vol. 32 (3)
iCEBc: A new predictor for hemodialysis need in patients with crush injury—experience from the february 6, 2023, Turkey earthquake
Objective: Early diagnosis and treatment of acute renal failure is critical for reducing mortality and morbidity in patients with crush syndrome (CS), which necessitates hemodialysis (HD) treatment in 75% of CS cases. This study aimed to evaluate whether the index of cardio electrophysiological balance‐corrected (iCEBc) and/or other electrocardiographic parameters could predict the need for HD among patients who had suffered from CS following the February 6, 2023 earthquakes in Kahramanmaraş, Turkey.Methods: This single‐center retrospective case‐control study included 130 patients diagnosed with CS. They were divided into two groups: the HD group (n = 56) and the non‐HD group (n = 74).Results: The study group had a mean age of 40.6 ± 16.1 years and 71 (54.6%) were males. iCEBc values in the HD group were significantly higher than those in the non‐HD group (p < 0.001). Multivariate regression revealed that high iCEBc (p = 0.029, odds ratio: 2.286, and 95% confidence intervals: 1.086–4.811), creatine kinase (p < 0.001, OR: 1.037, and 95% CI: 1.016–1.058), and white blood cell count (p = 0.002, OR: 1.112, and 95% CI: 1.038–1.191) were independent predictors of HD treatment. iCEBc > 4.67 predicted the need for HD with 75.0% sensitivity and 56.8% specificity. A new scoring system, ranging from a minimum of 0 to a maximum of 10 points, has been designed. In patients with a score of ≥5, the need for dialysis was approximately seven times higher (p < 0.001, OR: 6.623, and 95% CI: 3.002–14.612). The area under the curve (AUC) of the new scoring system for predicting dialysis necessity was 0.803 (95% CI: 0.729–0.876 and p < 0.001).Conclusion: iCEBc and new scoring system are a simple, rapid, repeatable, and inexpensive parameter that can effectively predict the need for HD treatment in patients with CS.
- 14 June 2025
- Published by Wiley in Hong Kong Journal of Emergency Medicine
- Vol. 32 (3)
Open AccessiCEBc: A new predictor for hemodialysis need in patients with crush injury—experience from the february 6, 2023, Turkey earthquake
Objective: Early diagnosis and treatment of acute renal failure is critical for reducing mortality and morbidity in patients with crush syndrome (CS), which necessitates hemodialysis (HD) treatment in 75% of CS cases. This study aimed to evaluate whether the index of cardio electrophysiological balance‐corrected (iCEBc) and/or other electrocardiographic parameters could predict the need for HD among patients who had suffered from CS following the February 6, 2023 earthquakes in Kahramanmaraş, Turkey.Methods: This single‐center retrospective case‐control study included 130 patients diagnosed with CS. They were divided into two groups: the HD group (n = 56) and the non‐HD group (n = 74).Results: The study group had a mean age of 40.6 ± 16.1 years and 71 (54.6%) were males. iCEBc values in the HD group were significantly higher than those in the non‐HD group (p < 0.001). Multivariate regression revealed that high iCEBc (p = 0.029, odds ratio: 2.286, and 95% confidence intervals: 1.086–4.811), creatine kinase (p < 0.001, OR: 1.037, and 95% CI: 1.016–1.058), and white blood cell count (p = 0.002, OR: 1.112, and 95% CI: 1.038–1.191) were independent predictors of HD treatment. iCEBc > 4.67 predicted the need for HD with 75.0% sensitivity and 56.8% specificity. A new scoring system, ranging from a minimum of 0 to a maximum of 10 points, has been designed. In patients with a score of ≥5, the need for dialysis was approximately seven times higher (p < 0.001, OR: 6.623, and 95% CI: 3.002–14.612). The area under the curve (AUC) of the new scoring system for predicting dialysis necessity was 0.803 (95% CI: 0.729–0.876 and p < 0.001).Conclusion: iCEBc and new scoring system are a simple, rapid, repeatable, and inexpensive parameter that can effectively predict the need for HD treatment in patients with CS.
- 14 June 2025
- Published by Taylor & Francis in Fetal and Pediatric Pathology
- p. 1-10
Fetal NT-proBNP Concentrations in Response to Maternal Anemia: A Study of Term Pregnancies
This study evaluates fetal N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in umbilical cord blood from anemic versus non-anemic term pregnancies. In this prospective case-control study, 90 pregnant women were divided into two groups: 45 with maternal anemia and 45 without. Umbilical cord blood NT-proBNP concentrations were analyzed, and maternal data including hemoglobin and ferritin levels were collected. NT-proBNP concentrations were significantly higher in the anemia group (844.42 ± 746.9 pg/mL vs 510.87 ± 378.52 pg/mL, p = 0.01). Maternal ferritin levels were significantly lower in the anemia group (10.02 ± 6.81 vs 37.02 ± 9.79, p < 0.001). A significant inverse relationship was found between hemoglobin and NT-proBNP concentrations (β = -76.27, p < 0.001). Elevated NT-proBNP concentrations in anemic pregnancies suggest a compensatory fetal response to hypoxia, highlighting its potential as a marker for fetal cardiovascular adaptation.
- 14 June 2025
- Published by Taylor & Francis in Fetal and Pediatric Pathology
- p. 1-10
Fetal NT-proBNP Concentrations in Response to Maternal Anemia: A Study of Term Pregnancies
This study evaluates fetal N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in umbilical cord blood from anemic versus non-anemic term pregnancies. In this prospective case-control study, 90 pregnant women were divided into two groups: 45 with maternal anemia and 45 without. Umbilical cord blood NT-proBNP concentrations were analyzed, and maternal data including hemoglobin and ferritin levels were collected. NT-proBNP concentrations were significantly higher in the anemia group (844.42 ± 746.9 pg/mL vs 510.87 ± 378.52 pg/mL, p = 0.01). Maternal ferritin levels were significantly lower in the anemia group (10.02 ± 6.81 vs 37.02 ± 9.79, p < 0.001). A significant inverse relationship was found between hemoglobin and NT-proBNP concentrations (β = -76.27, p < 0.001). Elevated NT-proBNP concentrations in anemic pregnancies suggest a compensatory fetal response to hypoxia, highlighting its potential as a marker for fetal cardiovascular adaptation.
- Open Access
- 7 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 1791
Isolated Liver Recurrence After Cytoreduction in High-Grade Serous Ovarian Carcinoma: Experience of a Tertiary Center in Turkey
Background: Serous epithelial ovarian cancer is typically diagnosed at an advanced stage and often recurs following treatment. Isolated organ recurrence is rare in this disease, making treatment planning a critical decision. Therefore, we investigated the survival rates of patients who developed isolated liver recurrence. Methods: The entire cohort included patients who underwent cytoreductive surgery between January 1993 and December 2020. We evaluated patients who completed primary chemotherapy after cytoreductive surgery based on their status of isolated liver recurrence. We created two groups: patients with isolated parenchymal recurrence and patients with isolated capsular recurrence. Staging was based on the International Federation of Gynecology and Obstetrics (FIGO) 2014 staging criteria. For patients treated before 2014, cancer staging was adapted to the FIGO 2014 system based on a surgical and pathological assessment. Results: The mean ages of patients with liver capsule and parenchymal recurrence at the time of primary surgery were 47 ± 10.6 and 49 ± 8.9 years, respectively. The median recurrence of patients with capsular recurrence was 13 (2–70) months. In patients with parenchymal recurrence, the duration was 10 months (4–80) and was statistically insignificant. While survival was 41.5 (5–120) months in patients with capsular recurrence, it was 34 (12–120) months in patients with parenchymal recurrence, but there was no statistical difference. Conclusions: In our 27 years’ of experience with EOC management, we have studied patients with isolated liver recurrences. The finding that either capsular or parenchymal liver recurrence has no significant impact on overall survival suggests that both types of recurrence can be managed with similar treatment and follow-up approaches. This observation could simplify patient management and improve outcomes by allowing clinicians to focus on optimal surgical and systemic treatment strategies rather than the anatomic pattern of recurrence.
- 7 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 1791
Open AccessIsolated Liver Recurrence After Cytoreduction in High-Grade Serous Ovarian Carcinoma: Experience of a Tertiary Center in Turkey
Background: Serous epithelial ovarian cancer is typically diagnosed at an advanced stage and often recurs following treatment. Isolated organ recurrence is rare in this disease, making treatment planning a critical decision. Therefore, we investigated the survival rates of patients who developed isolated liver recurrence. Methods: The entire cohort included patients who underwent cytoreductive surgery between January 1993 and December 2020. We evaluated patients who completed primary chemotherapy after cytoreductive surgery based on their status of isolated liver recurrence. We created two groups: patients with isolated parenchymal recurrence and patients with isolated capsular recurrence. Staging was based on the International Federation of Gynecology and Obstetrics (FIGO) 2014 staging criteria. For patients treated before 2014, cancer staging was adapted to the FIGO 2014 system based on a surgical and pathological assessment. Results: The mean ages of patients with liver capsule and parenchymal recurrence at the time of primary surgery were 47 ± 10.6 and 49 ± 8.9 years, respectively. The median recurrence of patients with capsular recurrence was 13 (2–70) months. In patients with parenchymal recurrence, the duration was 10 months (4–80) and was statistically insignificant. While survival was 41.5 (5–120) months in patients with capsular recurrence, it was 34 (12–120) months in patients with parenchymal recurrence, but there was no statistical difference. Conclusions: In our 27 years’ of experience with EOC management, we have studied patients with isolated liver recurrences. The finding that either capsular or parenchymal liver recurrence has no significant impact on overall survival suggests that both types of recurrence can be managed with similar treatment and follow-up approaches. This observation could simplify patient management and improve outcomes by allowing clinicians to focus on optimal surgical and systemic treatment strategies rather than the anatomic pattern of recurrence.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (2) , e20241313
The relationship between spexin and liver steatosis in polycystic ovary syndrome: a novel analysis using ultrasound-guided attenuation parameter
OBJECTIVE: This study aims to evaluate the relationship between spexin levels and nonalcoholic fatty liver disease in patients with polycystic ovary syndrome.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (2) , e20241313
Open AccessThe relationship between spexin and liver steatosis in polycystic ovary syndrome: a novel analysis using ultrasound-guided attenuation parameter
OBJECTIVE: This study aims to evaluate the relationship between spexin levels and nonalcoholic fatty liver disease in patients with polycystic ovary syndrome.